|  | FCCTX vs. Population-based cohort | |||
---|---|---|---|---|---|
Cancer | Age groups | IRR | 95% CI lower | 95% CI Upper | P values |
Breast cancer (n = 103) | 0–29 | 0.00 | 0.00 | 21.39 | 1.0000 |
30–49 | 1.71 | 1.02 | 2.68 | 0.0070* | |
50–69 | 1.54 | 1.06 | 2.14 | 0.0030* | |
70+ | 1.37 | 0.72 | 2.34 | 0.1495 | |
Urothelial cancer (n = 45) | 0–29 | 10.01 | 0.06 | 73.02 | 0.0955 |
30–49 | 0.50 | 0.00 | 3.62 | 1.0000 | |
50–69 | 0.90 | 0.41 | 1.70 | 0.7999 | |
70+ | 2.10 | 1.26 | 3.30 | 0.0003* | |
Lung cancer (n = 40) | 0–29 | 0.00 | 0.00 | 81.72 | 1.0000 |
30–49 | 1.20 | 0.27 | 3.32 | 0.6186 | |
50–69 | 0.50 | 0.26 | 0.87 | 0.0011* | |
70+ | 0.65 | 0.31 | 1.17 | 0.0864 | |
Pancreatic cancer (n = 21) | 0–29 | 0.00 | 0.00 | 348.69 | 1.0000 |
30–49 | 0.00 | 0.00 | 5.75 | 1.0000 | |
50–69 | 1.05 | 0.32 | 2.51 | 0.8450 | |
70+ | 2.21 | 1.12 | 4.38 | 0.0023* | |
Gastric cancer (n = 20) | 0–29 | 0.00 | 0.00 | 136.20 | 1.0000 |
30–49 | 5.87 | 1.57 | 15.02 | 0.0007* | |
50–69 | 0.77 | 0.14 | 2.35 | 0.8254 | |
70+ | 1.81 | 0.70 | 3.80 | 0.0811 | |
Eye tumours (n = 5) | 0–29 | 0.00 | 0.00 | 40.95 | 1.0000 |
30–49 | 0.00 | 0.00 | 18.09 | 1.0000 | |
50–69 | 7.73 | 1.76 | 21.45 | 0.0006* | |
70+ | 0.00 | 0.00 | 15.20 | 1.0000 |